6-K 1 d3252106k.htm

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2021

Commission File Number 001-37652

 

Midatech Pharma PLC

(Translation of registrant’s name into English)

 

Oddfellows House,

19 Newport Road,

Cardiff, CF24 0AA, United Kingdom

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F  x                Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  o

 

This Report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-233901) and Form F-1 (File No. 333-240984).

 

 

 

   
 

 

SUBMITTED HEREWITH

 

Attached to the Registrant’s Form 6-K filing for the month of March 2021, and incorporated by reference herein, is:

 

Exhibit No.

  Description
   
99.1  

Press release, dated March 25, 2021 entitled

 

“Non-binding Heads of Terms for MTX110 Co-development of MTX110 and

 

Unaudited Headline Results for the Year Ended 31 December 2020”

 

   
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Midatech Pharma PLC
     
     
Date: March 25, 2021 By: /s/ Stephen Stamp
   

Stephen Stamp

Chief Executive Officer, Chief Financial Officer

 

   
 

 

Exhibit Index

 

     

Exhibit No.

  Description
   
99.1  

Press release, dated March 25, 2021 entitled

 

“Non-binding Heads of Terms for MTX110 Co-development of MTX110 and

 

Unaudited Headline Results for the Year Ended 31 December 2020”